Andrew Moore has been a consultant for and/or received research grants from RB, Novartis, Grünenthal, and Menarini, some of whose products might be competitors of paracetamol is some circumstances.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback